Two Elderly Men with Myasthenia Gravis during Androgen Deprivation Therapy for Prostate Cancer

Intern Med. 2023 Aug 15;62(16):2413-2414. doi: 10.2169/internalmedicine.0474-22. Epub 2023 Jan 12.

Abstract

Myasthenia gravis (MG) development is female-dominant in younger patients and male-dominant in older patients. The reason for the sex-ratio inversion in elderly MG patients remains unclear. One possible explanation is the decrease in androgen secretion that occurs with aging, as androgen has an immunosuppressive function. We experienced two elderly men who developed MG after initiating androgen deprivation therapy (ADT) for treatment of prostate cancer and whose symptoms were ameliorated after ADT cessation. Our cases indicate that MG in older male patients can be caused by an androgen effect.

Keywords: androgen deprivation therapy; elderly male; goserelin; immunosenescence; myasthenia gravis; old man.

MeSH terms

  • Aged
  • Aging
  • Androgen Antagonists / adverse effects
  • Androgens
  • Humans
  • Male
  • Myasthenia Gravis* / chemically induced
  • Myasthenia Gravis* / drug therapy
  • Prostatic Neoplasms* / drug therapy

Substances

  • Androgen Antagonists
  • Androgens